Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $34.70M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $27.36M with 2,131.40% year-over-year growth. In the year 2023, Atara Biotherapeutics had annual revenue of $8.57M.

• Revenue (ttm): $34.70M
• Revenue Growth: -39.63%
• P/S Ratio: 1.56
• Revenue / Employee: $154,240
• Employees: 225
• Market Cap: 54.00M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.57M	-55.00M	-86.51%
Dec 31, 2022	63.57M	43.23M	212.55%
Dec 31, 2021	20.34M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.